Stay updated on Relatlimab + Nivolumab Bioavailability Clinical Trial

Sign up to get notified when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab + Nivolumab Bioavailability Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor technical update to the page revision.
    Difference
    0.1%
    Check dated 2026-03-11T15:33:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2. The prior funding-lapse notice (v3.4.1) has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:14:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a general site notice about funding and operation status, and updated the site revision tag from v3.4.0 to v3.4.1. These changes affect the website interface rather than the study details.
    Difference
    0.5%
    Check dated 2026-02-04T00:51:58.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated the revision label to v3.4.0, along with minor capitalization changes in labels like 'Last Update' and 'No FEAR Act'. These are UI and copy tweaks that do not affect study data or eligibility.
    Difference
    0.2%
    Check dated 2026-01-27T23:40:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this is a minor site maintenance update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T19:19:14.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A dedicated Locations section now lists New Jersey, replacing the former New Jersey Locations, which improves visibility of where the trial is conducted. The HHS Vulnerability Disclosure footer link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T07:39:46.000Z thumbnail image

Stay in the know with updates to Relatlimab + Nivolumab Bioavailability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.